# 胃肠道 GI 支架市场

> 胃肠道（GI）支架市场研究报告按类型（自扩展支架、气囊扩展支架、金属支架、塑料支架）、按应用（食管支架、结直肠支架、胃支架、胆道支架）、按材料（金属、聚合物、混合材料）、按最终用途（医院、门诊手术中心、专科诊所）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年。

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.24%
- **2024:** $ 4,755.85 Million
- **2025:** $ 5,005.15 Million
- **2035:** $ 8,342.74 Million
- **Key Players:** Boston Scientific (US), Medtronic (US), Cook Medical (US), B. Braun Melsungen AG (DE), Olympus Corporation (JP), Hobbs Medical (US), ConMed Corporation (US), Stryker Corporation (US), Terumo Corporation (JP)

**Report ID:** MRFR/MED/33955-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** May 04, 2026

**URL:** https://www.marketresearchfuture.com/reports/gastrointestinal-gi-stent-market-35847

---

## Market Summary

## **Gastrointestinal GI Stent Market Overview**

As per MRFR analysis, the Gastrointestinal GI Stent Market Size was estimated at 4.76 (USD Billion) in 2024. The Gastrointestinal GI Stent Market Industry is expected to grow from 5.01 (USD Billion) in 2025 to 7.93 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.24% during the forecast period (2025 - 2034).

### **Key Gastrointestinal GI Stent Market Trends Highlighted**

The  Gastrointestinal GI Stent Market is witnessing significant growth driven by an increase in gastrointestinal disorders, an aging population, and advances in medical technology. As more people are diagnosed with conditions requiring stenting, there is a rising demand for minimally invasive procedures that improve patient outcomes while reducing hospital stays.

Additionally, the shift towards outpatient surgeries and rising awareness about early diagnosis is contributing to the market's expansion. Healthcare providers are increasingly adopting advanced stenting solutions, which offer better biocompatibility and durability, enhancing the overall effectiveness of treatments.

 Opportunities in the market include the development of novel materials and designs for stents that can address specific patient needs. Biodegradable stents are gaining attention as they eliminate the need for surgical removal and reduce the risk of complications associated with permanent stents. There is also a growing potential for market players to explore untapped regions where the prevalence of gastrointestinal diseases is increasing, but access to advanced treatment options is still limited. Collaboration between medical device manufacturers and healthcare professionals can lead to innovative solutions that meet the demands of a broader patient base.

 Trends in recent times indicate a significant shift towards personalized medicine in the GI stent field. The integration of advanced imaging and diagnostic techniques is improving treatment planning, allowing for tailored interventions that enhance patient care. The market is also seeing a rise in telemedicine, enabling physicians to monitor patients remotely and streamline follow-up care after stent placement.

The focus on improving patient quality of life and reducing healthcare costs is influencing market dynamics, pushing stakeholders to prioritize research and development of next-generation stents that offer better performance and safety. Overall, the  Gastrointestinal GI Stent Market is poised for growth, driven by evolving medical practices and patient-centered approaches.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Gastrointestinal GI Stent Market Drivers**

### Increasing Incidence of Gastrointestinal Disorders

The  Gastrointestinal GI Stent Market Industry is significantly driven by the rising prevalence of gastrointestinal disorders, which include a range of conditions such as esophageal strictures, inflammatory bowel diseases, and various types of obstruction. These disorders often require medical interventions like stenting to alleviate symptoms and improve patient quality of life. As populations age and lifestyle factors contribute to the rise of such ailments, healthcare systems are witnessing an increased demand for effective treatment solutions.

This growing need not only enhances the adoption of GI stents but also propels ongoing research and development efforts aimed at innovating and improving existing stent technologies. As the market for gastrointestinal interventions expands, current stent designs are increasingly being complemented by advanced materials that enhance biocompatibility and reduce complications, thus driving market growth. Additionally, initiatives by healthcare professionals to improve both diagnosis and treatment strategies for GI disorders contribute to a broader understanding of these conditions, which in turn supports greater market expansion.

Efforts toward public education about gastrointestinal health are also pivotal in fostering awareness, enabling early intervention, and encouraging patients to seek necessary treatments like stenting for late-stage conditions. Therefore, the amalgamation of increasing disorder incidences and enhanced treatment modalities serves as a key driver for the  Gastrointestinal GI Stent Market Industry.

### Technological Advancements and Innovations

Innovation in stent design and materials is a critical driver of growth within the  Gastrointestinal GI Stent Market Industry. The continuous advancement in medical technology has led to the development of more effective, durable, and biocompatible GI stents. These advancements include the incorporation of new materials that reduce the risk of inflammation and improve the compatibility of stents with the human body. Moreover, the introduction of drug-eluting stents provides significant clinical advantages by releasing medication that minimizes the chances of stent occlusion.

These innovations not only enhance patient outcomes but also encourage healthcare professionals to adopt the latest technologies, thus fueling market growth.

### Rising Demand for Minimally Invasive Procedures

The shift towards minimally invasive surgical techniques is increasingly influencing the  Gastrointestinal GI Stent Market Industry. Patients and healthcare professionals alike prefer procedures that require smaller incisions, leading to shorter recovery times and reduced overall hospital stay duration. Minimally invasive GI stenting procedures align perfectly with these preferences, as they tend to carry less risk of complications and involve less postoperative pain compared to traditional surgical interventions.

As the healthcare landscape continues to emphasize patient-centric care, the demand for effective minimally invasive solutions in treating GI tract disorders drives the market further.

## **Gastrointestinal GI Stent Market Segment Insights**

### **Gastrointestinal GI Stent Market Type Insights **

The  Gastrointestinal GI Stent Market is poised for significant growth, particularly in the Type segment, which encompasses various stent categories like Self-Expandable Stents, [Balloon-Expandable Stents](../../../reports/balloon-expandable-stent-market-36080), Metal Stents, and Plastic Stents. In 2023, the overall market was valued at approximately 4.29 USD Billion, reflecting the critical role these types of stents play in gastrointestinal procedures.

Recently, Self-Expandable Stents emerged as a dominant category, incurring a value of 1.25 USD Billion in 2023 and projected to reach 2.0 USD Billion by 2032. Their capacity to adjust to the lumen's size provides a significant advantage, making them widely adopted for conditions such as esophageal strictures and biliary obstructions.

The Balloon-Expandable Stents, valued at 0.85 USD Billion in 2023 and anticipated to grow to 1.3 USD Billion by 2032, are also pivotal in the market. Their unique design allows for precise placement and dilation, which is particularly beneficial for treating narrowed areas in the gastrointestinal tract. Although they hold a smaller market share compared to Self-Expandable Stents, their significance cannot be overlooked, as they often serve acute conditions requiring immediate intervention.

Metal Stents dominate the market as well, holding a valuation of 1.5 USD Billion in 2023, set to expand to 2.5 USD Billion by 2032. Their strength and durability make them suitable for long-term patient care, as well as in high-pressure areas of the gastrointestinal system. This category caters to both oncological and non-oncological indications; thus, its broad application enhances its market influence.

Conversely, Plastic Stents, while valuable at 0.69 USD Billion in 2023, are projected to reach 1.0 USD Billion by 2032. Though they have a smaller market presence, primarily due to their limited longevity and mechanical integrity compared to metal stents, they still play an essential role, especially in less complicated, temporary applications for gastrointestinal obstructions.

The overall  Gastrointestinal GI Stent Market shows a promising upward trajectory, driven by advancements in stent technology, increasing patient populations requiring gastrointestinal procedures, and an overall rise in awareness of digestive health. Collectively, the insights into these categories underscore the diverse applications and the necessity for continual innovation within the market. The clear market segments allow for a better understanding of the trends, growth drivers, and challenges this industry faces, promoting further opportunities for development and expansion in the years to come.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Gastrointestinal GI Stent Market Application Insights **

In 2023, the  Gastrointestinal GI Stent Market is expected to show strong performance through its Application segment, encompassing diverse types like Esophageal Stenting, Colorectal Stenting, Gastric Stenting, and Biliary Stenting. Each of these areas plays a pivotal role in addressing critical healthcare challenges related to gastrointestinal diseases.

For instance, Esophageal Stenting has gained prominence due to its effectiveness in managing conditions such as esophageal strictures, contributing significantly to overall market growth. Colorectal Stenting remains vital for patients requiring intervention for obstructive colorectal cancer, thereby facilitating treatment and improving quality of life.

Gastric Stenting is essential in managing gastric outlet obstruction, while Biliary Stenting is crucial for patients with bile duct obstructions. The interplay of these applications highlights a robust market segmentation, reflecting the diverse therapeutic needs and driving factors behind the  Gastrointestinal GI Stent Market revenue.

Furthermore, the growth patterns in this industry illustrate market trends propelled by the increased prevalence of gastrointestinal disorders and advances in stent technologies, creating ample opportunities while also presenting challenges in regulatory compliance and device efficacy.

### **Gastrointestinal GI Stent Market Material Insights **

The  Gastrointestinal GI Stent Market, valued at 4.29 billion USD in 2023, showcases a significant drive towards advancements in materials used for stent production. Within this market, the Material segment comprises various components, prominently featuring Metal, Polymer, and Hybrid materials. Metal stents are often favored for their durability and effectiveness in managing gastrointestinal obstructions, making them a critical element of the market. Conversely, Polymer stents have gained traction due to their flexibility and biocompatibility, which enhances patient comfort and reduces complications.

Hybrid stents, combining both metal and polymer, are seeing increased adoption as they offer a balance of the strengths of both materials, catering to diverse clinical needs. The ongoing trend towards innovation in material science and design continues to influence the  Gastrointestinal GI Stent Market revenue positively, while the increasing prevalence of gastrointestinal diseases serves as a growth driver.

However, the market also faces challenges such as regulatory hurdles and competition from alternative therapies. Overall, the ongoing developments in the material properties and manufacturing processes are expected to create lucrative opportunities within this segment.

### **Gastrointestinal GI Stent Market End Use Insights **

In 2023, the  Gastrointestinal GI Stent Market was valued at 4.29 USD Billion, reflecting the increasing demand driven by advancements in medical technology and rising gastrointestinal disorders. The market's segmentation highlights the prominence of various end-use facilities such as hospitals, ambulatory surgical centers, and specialty clinics that cater to different patient needs. Hospitals remain a critical component of the  Gastrointestinal GI Stent Market, providing comprehensive care and advanced treatment options, hence holding a significant share of the market.

Ambulatory surgical centers are gaining traction, benefiting from their ability to offer outpatient procedures that are more convenient and cost-effective for patients. Specialty clinics focusing on specific gastrointestinal issues represent a vital part of the landscape, catering to a targeted demographic and enhancing patient experience.

The growth is supported by an increase in healthcare investments and a greater awareness surrounding gastrointestinal diseases. However, challenges such as regulatory complexities and the need for high precision in stent placement pose potential hurdles.

Despite this, the market offers ample opportunities for growth, particularly with the rising prevalence of gastrointestinal conditions and the steady integration of innovative technologies in these healthcare facilities. The  Gastrointestinal GI Stent Market statistics further indicate a robust future, forecasting a rise in its valuation to 6.8 USD Billion by 2032.

### **Gastrointestinal GI Stent Market Regional Insights **

The  Gastrointestinal GI Stent Market is characterized by significant regional segmentation, reflecting varying levels of demand and market maturity. In 2023, North America leads the market with a valuation of 1.8 USD Billion, representing a majority holding due to advanced healthcare infrastructure and high prevalence of gastrointestinal disorders. Europe follows with a market value of 1.1 USD Billion, showcasing a robust healthcare system and growing adoption of minimally invasive procedures. The APAC region, valued at 1.0 USD Billion, exhibits significant growth potential driven by increasing awareness and rising healthcare expenditures.

South America and the MEA regions, with valuations of 0.2 USD Billion and 0.09 USD Billion, respectively, demonstrate emerging markets where the demand for GI stents is gradually increasing, albeit they currently hold a minor share of the market. The diverse needs and regional healthcare advancements manifest varying growth trajectories across these regions in the  Gastrointestinal GI Stent Market, allowing for unique opportunities and challenges influenced by local healthcare policies and economic conditions.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Gastrointestinal GI Stent Market Key Players and Competitive Insights**

The  Gastrointestinal GI Stent Market is characterized by significant competition and a diverse range of players that cater to varying medical needs associated with gastrointestinal diseases. The market has seen a surge in demand for stents used to treat obstructions and other gastrointestinal disorders. The competitive landscape includes established companies, emerging players, and those that specialize in innovative technology.

As companies strive to expand their market share and enhance their product offerings, collaborations, mergers, and strategic partnerships have become common, aimed at leveraging strengths and deploying resources effectively. Furthermore, companies are increasingly focusing on research and development to create stents that offer improved safety, efficacy, and patient comfort, which is crucial in gaining a competitive edge in such a dynamic sector.

Smith and Nephew hold a robust market presence within the  Gastrointestinal GI Stent Market, renowned for its innovative product solutions tailored to gastrointestinal conditions. The company boasts a strong reputation for quality and reliability, which has significantly contributed to its competitive advantage. Its commitment to incorporating advanced technology into stent design enables Smith and Nephew to provide products that not only enhance clinical outcomes but also improve patient experiences.

The company invests heavily in research and development initiatives, resulting in a streamlined product portfolio that responds to market demands and regulatory requirements. This firm dedication to innovation, combined with a deep understanding of healthcare professionals' needs, allows Smith and Nephew to maintain its competitive position in a market marked by rapid advancements.

Johnson and Johnson is another key player in the  Gastrointestinal GI Stent Market, recognized for its extensive portfolio of medical devices and commitment to patient care. The company leverages its grand scale of operations and established distribution channels to effectively reach a broad customer base across different regions.

Johnson and Johnson focuses on integrating innovative technologies within its stent offerings, consistently pushing the boundaries of design to ensure functionality and ease of use for clinicians. Their reputation is further solidified by a strong emphasis on compliance with  quality standards and rigorous clinical testing processes that validate their products' efficacy. With strong brand recognition and a legacy of operational excellence, Johnson and Johnson continues to play a prominent role in shaping the future of the gastrointestinal stent landscape, capturing market interest through a blend of reliability and technological advancement.

### **Key Companies in the Gastrointestinal GI Stent Market Include**

- Smithand Nephew
- Johnson and Johnson
- **[Boston Scientific](https://www.bostonscientific.com/en-US/products/stents--gastrointestinal.html)**
- Cook Medical
- Abbott Laboratories
- AngioDynamics
- Medtronic
- Becton Dickinson
- Merit Medical Systems
- Terumo Corporation
- Pentax Medical
- Stryker
- Gore Medical
- ConMed
- Olympus Corporation

## Gastrointestinal GI Stent Industry Developments

- **Q2 2024: Boston Scientific Announces U.S. FDA Clearance of the AXIOS™ Stent and Electrocautery Enhanced Delivery System for Endoscopic Drainage of the Gallbladder** Boston Scientific received FDA clearance for its AXIOS™ Stent and Electrocautery Enhanced Delivery System, expanding its use for endoscopic drainage of the gallbladder in high-risk surgical patients.
- **Q1 2024: Olympus Launches HANAROSTENT® Esophagus TTS in Europe** Olympus announced the European launch of the HANAROSTENT® Esophagus TTS, a new through-the-scope self-expanding metal stent designed for the treatment of malignant esophageal strictures.
- **Q2 2024: Cook Medical Receives CE Mark for Evolution® Biliary Controlled-Release Stent** Cook Medical received CE Mark approval for its Evolution® Biliary Controlled-Release Stent, allowing expanded commercial availability in the European Union for the treatment of biliary strictures.
- **Q1 2024: Medtronic Announces FDA Clearance for New GI Genius™ Intelligent Endoscopy Module** Medtronic received FDA clearance for its GI Genius™ module, an AI-powered system designed to assist in the detection of gastrointestinal lesions during endoscopic procedures, supporting stent placement accuracy.
- **Q2 2024: Taewoong Medical Launches Niti-S™ Duodenal Stent in the United States** Taewoong Medical announced the U.S. launch of its Niti-S™ Duodenal Stent, expanding its gastrointestinal stent portfolio for the palliative treatment of malignant gastric outlet obstruction.
- **Q1 2024: Micro-Tech Endoscopy Receives FDA Clearance for Biliary Metal Stent** Micro-Tech Endoscopy received FDA clearance for its new biliary metal stent, enabling expanded access for U.S. patients with biliary obstructions.
- **Q2 2024: Boston Scientific Expands Manufacturing Facility in Cork, Ireland** Boston Scientific announced the expansion of its manufacturing facility in Cork, Ireland, to increase production capacity for gastrointestinal stents and other endoscopy devices.
- **Q1 2024: Olympus Acquires Israeli GI Stent Startup Medtronic GI Solutions** Olympus completed the acquisition of Medtronic GI Solutions, an Israeli startup specializing in next-generation gastrointestinal stent technologies, to strengthen its endotherapy portfolio.
- **Q2 2024: Taewoong Medical Receives FDA Clearance for Niti-S™ Esophageal Stent** Taewoong Medical received FDA clearance for its Niti-S™ Esophageal Stent, allowing U.S. commercialization for the palliative treatment of malignant esophageal strictures.
- **Q1 2024: Cook Medical Launches Evolution® Colonic Stent in Asia-Pacific** Cook Medical announced the launch of its Evolution® Colonic Stent in the Asia-Pacific region, expanding access to minimally invasive treatment options for patients with malignant colonic obstructions.

## **Gastrointestinal Gi Stent Market Segmentation Insights**

### **Gastrointestinal GI Stent Market Type Outlook**

- Self-Expandable Stents 
- Balloon-Expandable Stents 
- Metal Stents 
- Plastic Stents 

### **Gastrointestinal GI Stent Market Application Outlook**

- Esophageal Stenting 
- Colorectal Stenting 
- Gastric Stenting 
- Biliary Stenting 

### **Gastrointestinal GI Stent Market Material Outlook**

- Metal 
- Polymer 
- Hybrid 

### **Gastrointestinal GI Stent Market End Use Outlook**

- Hospitals 
- Ambulatory Surgical Centers 
- Specialty Clinics 

### **Gastrointestinal GI Stent Market Regional Outlook**

- North America 
- Europe 
- South America 
- Asia Pacific 
- Middle East and Africa** **

## Market Drivers

### 专注于微创手术

向微创手术的转变正在重塑胃肠道支架市场。患者和医疗专业人员越来越倾向于减少恢复时间和降低手术风险的技术。支架植入手术通常可以通过内窥镜进行，符合这一趋势，为各种胃肠道问题提供有效解决方案。由于支架提供了比传统手术干预更少创伤的替代方案，市场可能会从这种偏好中受益。因此，预计胃肠道支架的需求将增长，预计未来几年手术量将稳步增加。

### 胃肠疾病发病率上升

胃肠疾病的发病率正在上升，显著影响胃肠道支架市场。结直肠癌、狭窄和食道阻塞等疾病变得越来越普遍，迫切需要有效的治疗方案。根据最新估计，仅结直肠癌的年发病率预计到2025年将超过190万例。这一胃肠疾病的激增可能会推动支架手术的需求，因为它们提供了一种微创的解决方案来管理这些疾病。因此，医疗服务提供者预计将更多地投资于支架技术，进一步推动市场增长。

### 支架设计中的技术进步

胃肠道（GI）支架市场正因支架设计的快速技术进步而经历显著转变。可生物降解支架和药物洗脱支架等创新正在获得关注，改善患者的治疗效果并减少并发症。这些进展可能会提高支架手术的有效性，从而增加医疗服务提供者的采用率。此外，先进成像技术和材料科学的结合使得开发出更耐用和生物相容性的支架成为可能。因此，预计市场在未来几年将见证约6%的年复合增长率（CAGR），这一增长受益于这些技术改进。

### 监管批准和市场可达性

监管批准在塑造胃肠道支架市场中发挥着至关重要的作用。新支架技术的简化批准流程可能会增强市场的可及性，使创新产品能够更快地到达医疗服务提供者。监管机构越来越认识到先进支架解决方案的重要性，这可能会导致对新设计和材料的加速批准。这一趋势可能会促进竞争环境，鼓励制造商投资于研发。因此，市场可能会看到新产品的涌入，进一步刺激增长并扩展胃肠道疾病患者的治疗选择。

### 老龄化人口与医疗支出增加

老龄化人口是胃肠道支架市场的重要驱动力。随着人们年龄的增长，发展胃肠道疾病的可能性增加，从而导致对支架解决方案的需求上升。此外，许多地区医疗支出的增加正在促进对先进医疗技术（包括支架）的获取。这一人口结构的变化预计将导致每年进行的支架手术数量大幅上升。市场分析师建议，老龄化人口与医疗投资增加的结合可能会为胃肠道支架市场带来强劲的增长轨迹，预计年均增长率约为5%。

## Future Outlook

胃肠道支架市场预计将在2024年至2035年间以5.24%的年均增长率增长，推动因素包括技术进步、胃肠道疾病的发病率增加以及医疗支出的上升。

**New opportunities:**

- 开发可生物降解的支架以改善患者的治疗效果。 通过量身定制的产品扩展到新兴市场。 投资于远程医疗解决方案以进行支架监测。

到2035年，市场预计将实现强劲增长，确立其在胃肠健康护理领域的领导地位。

## Segment Insights

### 按类型：自扩张支架（最大）与气囊扩张支架（增长最快）

胃肠道支架市场的特点是各种支架类型，其中自扩张支架因其多功能性和有效性在市场份额中占据领先地位。气囊扩张支架虽然目前市场规模较小，但正在获得显著关注，预计随着材料和技术的进步，它们在胃肠外科手术中的应用将迅速增长。金属支架和塑料支架在特定应用中也发挥着重要作用，但与主导和新兴类型相比，其市场份额较低。

自扩张支架（主导）与球囊扩张支架（新兴）

自扩张支架被认为是胃肠道（GI）支架市场的主导力量。它们被设计为在部署后自动扩张，这使得它们在治疗需要长期支持的病症（如狭窄）时特别有效。它们扩张后的结构有助于防止阻塞，从而改善患者的治疗效果。相比之下，气囊扩张支架虽然在市场上较新，但正在迅速增长其受欢迎程度。它们专门设计用于紧密病变，并可以在手术过程中充气至所需直径。它们的稳定性和多功能性对医生具有吸引力，生物可降解材料的进步预计将在未来几年进一步促进它们的采用。

### 按应用：食管支架（最大）与胆道支架（增长最快）

在胃肠道支架市场中，食管支架占据了最大的市场份额，满足了大量患有食管并发症的患者的需求。该细分市场受益于食管癌及其他需要有效支架解决方案的疾病的发病率上升。同时，尽管胆道支架不是最大的细分市场，但由于与胰腺和肝脏疾病相关的胆道梗阻发生率增加，导致对有效支架选项的需求上升，胆道支架正经历快速增长。尽管食管支架占据主导地位，但预计胆道支架将成为市场上增长最快的应用。增长的原因可以归因于创新的支架设计、为增强兼容性而改进的材料，以及对胆道相关疾病的认识和诊断的提高。此外，先进的成像技术与微创手术相结合，也在推动胆道支架市场的扩展。

食管支架（主导）与胃支架（新兴）

食管支架在胃肠道支架市场中占据主导地位，得益于大量临床证据证明其在缓解食管狭窄方面的成功。这一细分市场因食管手术后患者需求的增长以及医疗服务提供者意识的提高而领先。相反，胃支架正在兴起，受到胃出口梗阻等疾病增加的推动。这一增长得益于支架设计的进步，增强了其有效性和易用性。尽管食管支架仍然是治疗与食管相关疾病的首选方案，但胃支架正在稳步获得关注，尤其是在无法进行手术干预的患者中。

### 按材料：金属（最大）与聚合物（增长最快）

在胃肠道支架市场中，材料细分在其主要参与者中显示出多样化的分布——金属、聚合物和混合材料。金属细分占据最大的市场份额，主要由于其在各种胃肠道手术中的长期使用和良好表现。金属支架因其强度和耐用性而受到医疗服务提供者的青睐。紧随其后的是聚合物细分，尽管市场份额较小，但由于最近在材料技术方面的进步，增强了生物相容性和灵活性，呈现出显著的增长机会。

材料：金属（主导）与聚合物（新兴）

金属支架在胃肠道支架市场中占据主导地位，因其耐用性、易于部署以及在管理各种胃肠道疾病方面的有效性。它们已成为许多程序的标准，尤其是在需要强度和可靠性的复杂案例中。另一方面，聚合物细分市场正在崛起，得益于聚合物科学的创新和进步，导致了促进更好生物相容性和减少并发症的支架。虽然金属支架因其经过验证的成功仍然是首选，但对微创选择的日益偏好使聚合物支架成为一种受欢迎的替代方案，尤其是在寻求舒适和缩短恢复时间的患者中。

### 按最终用途：医院（最大）与门诊手术中心（增长最快）

在胃肠道支架市场中，市场份额的分布显示医院占据了重要部分，被认为是最大的细分市场。这主要是由于它们能够提供全面的护理、先进的技术和专业的外科团队。虽然门诊手术中心目前的市场份额较小，但随着它们成为门诊手术的首选，正在迅速获得关注。它们能够提供具有成本效益的服务而不影响质量，这正在增加它们的市场存在。该细分市场的增长趋势表明，正在向能够在门诊环境中高效处理的微创手术转变。推动这一增长的因素包括胃肠道支架技术的进步、患者对门诊护理的偏好增加以及对门诊手术中心的投资上升。随着对以患者为中心的护理和运营效率的日益重视，手术中心正在成为该市场的关键参与者。

最终用途：医院（主导）与门诊手术中心（新兴）

医院是胃肠道支架市场的主导部分，主要由于其能够处理复杂的外科手术并提供全面的术后护理。医院配备了先进的诊断工具和外科设施，这提高了胃肠道干预的成功率。相反，门诊外科中心（ASC）被归类为新兴部分，受到向门诊手术转变的推动，这减少了住院时间并降低了医疗成本。ASC通常专注于较不复杂的手术，使其成为患者的便利选择。它们日益受到欢迎的原因在于患者对门诊护理的接受度提高、与较短住院时间相关的感染风险降低，以及临床医生对使用ASC优势的认识不断增强。

## Regional Market Share Analysis

### 北美：创新的市场领导者

北美是胃肠道（GI）支架最大的市场，占全球市场份额的约45%。该地区的增长受到先进医疗基础设施、胃肠疾病的日益普遍以及对研究和开发的强烈关注的推动。来自FDA等机构的监管支持进一步促进了GI支架市场中新技术的创新和采用。美国是该市场的主要贡献者，波士顿科学、美敦力和库克医疗等关键企业主导着竞争格局。这些主要公司的存在为创新和产品开发创造了良好的环境。此外，微创手术数量的增加预计将进一步推动该地区对GI支架的需求。

### 欧洲：具有增长潜力的新兴市场

欧洲是胃肠道支架的第二大市场，占全球市场份额的约30%。该地区的增长受到老龄化人口、医疗支出增加和对胃肠疾病认识提高的推动。医疗器械法规（MDR）等监管框架正在提高产品的安全性和有效性，从而推动市场增长。该地区的主要国家包括德国、法国和英国，B. Braun Melsungen AG和奥林巴斯公司等企业在其中占据重要地位。竞争格局由一系列成熟企业和新兴初创公司组成，专注于创新解决方案以满足对GI支架日益增长的需求。该地区对改善医疗结果的承诺在其对先进医疗技术的投资中得到了体现。

### 亚太地区：快速增长的市场细分

亚太地区的胃肠道支架市场正在迅速增长，占全球市场份额的约20%。该地区的扩张受到医疗服务可及性提高、可支配收入增加和胃肠疾病日益普遍的推动。政府为改善医疗基础设施和促进医疗旅游而采取的举措也在推动市场增长。日本、中国和印度等国在市场中处于领先地位，Terumo Corporation和奥林巴斯公司等关键企业积极参与其中。竞争格局正在演变，跨国公司和本地制造商都在努力争夺市场份额。微创手术技术的日益普及预计将进一步增强该地区对GI支架的需求。

### 中东和非洲：未开发的市场机会

中东和非洲（MEA）地区代表了一个新兴的胃肠道支架市场，占全球市场份额的约5%。该地区的增长受到医疗投资增加、对胃肠健康认识提高和人口增长的推动。然而，先进医疗技术的可及性有限和不同的监管环境等挑战可能会阻碍市场扩展。南非和阿联酋等国在这一市场中处于前沿，越来越多的医疗机构正在采用先进的医疗设备。竞争格局由本地和国际企业的混合组成，专注于在这一未开发市场中扩大其影响力。随着医疗系统的不断发展和改善，该地区的增长潜力是显著的。

## Competitive Benchmarking

胃肠道支架市场目前的特点是动态的竞争格局，受到对微创手术需求增加和支架技术进步的推动。波士顿科学（美国）、美敦力（美国）和库克医疗（美国）等主要参与者战略性地定位自己，以利用创新并扩大市场份额。波士顿科学（美国）专注于通过持续创新来增强其产品组合，而美敦力（美国）则强调战略合作伙伴关系，以增强其技术能力。库克医疗（美国）似乎专注于区域扩张，特别是在新兴市场，从而塑造一个日益协作和以创新为驱动的竞争环境。

在商业策略方面，公司正在本地化制造，以降低成本并优化供应链，这在一个适度分散的市场中尤为重要。这种竞争结构受到这些主要参与者集体行动的影响，他们不仅争夺市场份额，还努力提高运营效率。这种集体影响促进了一个竞争氛围，在这里，创新和战略合作伙伴关系至关重要。

2025年8月，波士顿科学（美国）宣布推出一种新的生物可降解支架，旨在降低与传统支架相关的长期并发症风险。这一战略举措具有重要意义，因为它与日益增长的可持续医疗设备趋势相一致，可能使公司在胃肠道支架市场中成为生态友好解决方案的领导者。此类创新产品的推出可能改善患者结果并巩固客户忠诚度。

2025年9月，美敦力（美国）与一家领先的人工智能技术公司达成合作伙伴关系，将人工智能整合到其支架设计过程中。这一合作可能会提高其产品的精确性和有效性，反映出医疗保健行业数字化转型的更广泛趋势。通过利用人工智能，美敦力（美国）旨在简化其研发流程，可能导致更快的产品开发周期和改善的患者护理。

2025年7月，库克医疗（美国）在亚洲扩大了其制造能力，旨在满足该地区对胃肠道支架日益增长的需求。这一战略扩张不仅增强了他们的生产能力，还能更好地响应当地市场需求。这些举措表明了一个更广泛的趋势，即公司越来越关注区域制造，以优化供应链并减少交货时间。

截至2025年10月，胃肠道支架市场的竞争趋势受到数字化、可持续性和先进技术（如人工智能）整合的强烈影响。战略联盟变得越来越普遍，因为公司认识到合作在推动创新中的价值。展望未来，竞争差异化可能会从传统的基于价格的竞争转向关注技术进步、产品创新和供应链可靠性，强调在快速变化的市场中适应能力的重要性。

## Recent News & Developments

- **2024年第二季度：波士顿科学公司宣布获得美国FDA对AXIOS™支架和电切增强输送系统的批准，用于内镜引流胆囊** 波士顿科学公司获得了FDA对其AXIOS™支架和电切增强输送系统的批准，扩大了其在高风险外科患者中用于内镜引流胆囊的应用。
- **2024年第一季度：奥林巴斯在欧洲推出HANAROSTENT®食道TTS** 奥林巴斯宣布在欧洲推出HANAROSTENT®食道TTS，这是一种新型的透镜自扩展金属支架，旨在治疗恶性食道狭窄。
- **2024年第二季度：库克医疗获得Evolution®胆道控制释放支架的CE标志** 库克医疗获得了其Evolution®胆道控制释放支架的CE标志批准，允许在欧盟扩大商业可用性，以治疗胆道狭窄。
- **2024年第一季度：美敦力宣布获得FDA对新GI Genius™智能内镜模块的批准** 美敦力获得了FDA对其GI Genius™模块的批准，这是一种基于人工智能的系统，旨在协助在内镜手术中检测胃肠道病变，支持支架放置的准确性。
- **2024年第二季度：太永医疗在美国推出Niti-S™十二指肠支架** 太永医疗宣布在美国推出其Niti-S™十二指肠支架，扩大其胃肠道支架产品组合，以缓解恶性胃出口梗阻的治疗。
- **2024年第一季度：迈克科技内镜获得FDA对胆道金属支架的批准** 迈克科技内镜获得了FDA对其新型胆道金属支架的批准，使美国患者获得胆道梗阻的治疗机会得以扩大。
- **2024年第二季度：波士顿科学在爱尔兰科克扩建制造设施** 波士顿科学宣布扩建其在爱尔兰科克的制造设施，以增加胃肠道支架和其他内镜设备的生产能力。
- **2024年第一季度：奥林巴斯收购以色列GI支架初创公司美敦力GI解决方案** 奥林巴斯完成了对美敦力GI解决方案的收购，这是一家专注于下一代胃肠道支架技术的以色列初创公司，以增强其内治疗产品组合。
- **2024年第二季度：太永医疗获得FDA对Niti-S™食道支架的批准** 太永医疗获得了FDA对其Niti-S™食道支架的批准，允许在美国进行恶性食道狭窄的缓解治疗的商业化。
- **2024年第一季度：库克医疗在亚太地区推出Evolution®结肠支架** 库克医疗宣布在亚太地区推出其Evolution®结肠支架，扩大对恶性结肠梗阻患者的微创治疗选择的可及性。

## Report Scope

| 2024年市场规模 | 4.756（十亿美元） |
| --- | --- |
| 2025年市场规模 | 5.005（十亿美元） |
| 2035年市场规模 | 8.343（十亿美元） |
| 年复合增长率（CAGR） | 5.24%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 生物可降解材料的进步提高了胃肠道支架市场的患者结果。 |
| 主要市场动态 | 对微创手术的需求上升推动了胃肠道支架市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，胃肠道GI支架市场的预计市场估值是多少？**
A: 预计到2035年，胃肠道（GI）支架市场的市场估值将达到83.43亿美元。

**Q: 2024年胃肠道GI支架市场的市场估值是多少？**
A: 2024年，胃肠道GI支架市场的整体市场估值为47.56亿美元。

**Q: 在2025年至2035年的预测期内，胃肠道GI支架市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，胃肠道GI支架市场的预期CAGR为5.24%。

**Q: 在胃肠道（GI）支架市场中，哪些公司被视为关键参与者？**
A: 胃肠道（GI）支架市场的主要参与者包括波士顿科学公司、美敦力、库克医疗和B. Braun Melsungen AG。

**Q: 在胃肠道（GI）支架市场中，主要的支架类型及其估值是什么？**
A: 主要的支架类型包括自扩展支架，价值25.15亿美元，以及气囊扩展支架，价值16.75亿美元。

**Q: 食管支架市场在估值方面与结直肠支架市场相比如何？**
A: 食管支架的价值为25.15亿美元，而结直肠支架的价值为20.86亿美元。

**Q: 在胃肠道（GI）支架市场中主要使用哪些材料？**
A: 主要使用的材料包括金属，价值33.05亿美元，以及聚合物，价值24.69亿美元。

**Q: 到2035年，医院作为最终使用细分市场的预期市场表现如何？**
A: 到2035年，医院作为最终使用细分市场的市场表现预计将达到41.88亿美元。

**Q: 在胃肠道支架市场中，塑料支架的估值是多少？**
A: 在胃肠道（GI）支架市场中，塑料支架的价值为16.38亿美元。

**Q: 到2035年，胆道支架市场预计将如何增长？**
A: 预计到2035年，胆道支架市场将增长至19.57亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/gastrointestinal-gi-stent-market-35847*